ABSIRACF Tetrafluoroethylene (TFE) was evaluated for carcinogenicity in inhalation studies because of its high use in the production of Teflon. There was clear evidence of hepatocarcinogenic activity in B6C3FI mice after 2 yr of TFE exposure. The present study was designed to characterize the mutation profiles of H-and K-ms oncogenes in liver neoplasms in mice after exposure to 0, 312. 625, or 1,250 ppm TFE. ros mutations were identified by restriction fragment length polymorphism, single-stranded conformation polymorphism analysis, and direct sequencing of polymerase chain reaction amplified-DNA isolated from frozen or paraffin-embedded liver neoplasms. A low frequency (15%. 9/59) of H-ms codon 61 mutations was detected in hepatocellular neoplasms when compared with the higher frequency (5970 of this study and 56% of historical data) in spontaneously occumng liver neoplasms. There was no difference in the mutation frequency or spectrum among exposure groups or between benign and malignant hepatocellular neoplasms.
INTRODUCTION
Tetrafluoroethylene (TFE) is used largely in the production of Teflon and other polymers (12). The National Toxicology Program (NTP) recently completed 2-yr TFE inhalation studies in male and female B6C3F1 mice and F344/N rats based on the high potential for human exposure to this chemical. There was clear evidence (p I 0.01, the logistic regression test and/or the life table test) of carcinogenic activity of TFE in male and female B6C3Fl mice based on increased incidences of hepatocellular neoplasms (17) .
Results from several in vitro studies have suggested that TFE is not mutagenic. TFE and its cysteine conjugates were not mutagenic in Saltuonella typhiitiuriiun with or without metabolic activation (10, 12) . In addition, no increase in the frequency of micronucleated normochromatic erythrocytes was detected in peripheral blood samples obtained from mice at the end of the 13-wk inhalation studies with TFE (17). Spontaneously occurring liver neoplasms have been found in B6C3F, mice with an approximate incidence of 44% in control males and of 25% in control females by 2 yr of age (NTP, unpublished data, 1997). Chemically induced tumors in mice have a high frequency of H-rus proto-oncogene activation, particularly by point mutations at codons 12, 13, 61, or 117 (2, 15) . The frequency of ras activation in these tumors is often greater than that detected in spontaneously occurring tumors (19), and sometimes there is evidence for chemical specificity in the pattern of proto-oncogene activation (15, 26) . The specific types of rus oncogene mutations induced by a chemical carcinogen may agree with what is expected, based on the DNA adducts formed by that agent (26,28). Even for "nongenotoxic" carcinogens, the pattern of ras gene mutations in tumors can give clues about the mechanism of tumorigenesis (6, 8, 15) . For example, liver tumors in B6C3FI mice treated chronically with methylene chloride exhibit an H-ras mutation frequency and pattern identical to those detected in spontaneous tumors, indicating that methylene chloride gives a growth advantage to those cells with spontaneous H-rus mutations as well as to those cells that do not have H-rus mutations (6). In contrast, liver tumors that arise in mice treated with phenobarbital have a significantly reduced proportion of rus mutations, suggesting that cells without ras mutations are involved in hepdtocarcinogenesis caused by this compound (8).
In the present study, liver neoplasms were examined for point mutations in the Hand K-ras proto-oncogenes.
Activation (by mutation) of ras genes alters signal transduction and growth control and contributes to the transformation of normal cells into neoplastic cells (2).
MATERIALS AND METHODS Liver Neoplusins. Male and female B6C3F1 mice, 50 mice per group, were exposed to 0, 312, 625, or 1,250 646 0192-6233/98$3.00+$0.00 ppm TFE by whole body inhalation for 6 hr per day, 5 days per week, for 2 yr. At necropsy, liver neoplasms were fixed in 10% neutral-buffered formalin, routinely processed, embedded in paraffin, sectioned to a thickness of 5 pm, and stained with hematoxylin and eosin. Subsequently, 6 unstained serial sections (10 pm thick) were prepared from paraffin blocks containing hepatocellular adenomas or carcinomas for isolation of DNA for polymerase chain reaction (PCR)-based assays. In order to isolate adequate amounts of DNA, liver neoplasms greater than 1 mm in diameter were identified and used for analysis. Based on the size criteria, a total of 66 paraffinembedded liver neoplasms were examined for genetic alterations in the H-ms gene. These included 53 neoplasms from TFE-exposed mice and 13 neoplasms from control mice. Also, 13 frozen liver neoplasms (4 from controls and 9 from exposed mice) were evaluated for H-ms and K-ras mutations. For the liver neoplasms from which frozen and paraffin-embedded tissues were available, both were examined to confirm the mutations.
DNA Zsolatioii. The DNA isolation procedure has been described previously (14, 22) . The paraffin-embedded tissue was deparaffinized and rehydrated before being digested with proteinase K. The frozen tumor tissue was digested with 10 mg/ml pronase in 1% sodium dodecyl sulfate in Tris-NaC1-EDTA (TNE) buffer (10 mi Tris, 150 mi NaCl, and 2 mi EDTA disodium salt, pH 7.5).
DNA was extracted with phenol and chloroform and precipitated with ethanol. DNA was quantified by measuring optical density at 260 nm, and a 200 ng sample was used for each amplification reaction.
DNA Aniplificatioii. DNA was amplified by the PCR (21, 22), and details of the use of nested primers for Kras at codons 12, 13, and 61 and H-ras at codon 117 have been described previously (5, 6, 11).
Restriction Fragment Length Polyniorphic Zdentificatioii. A nonradioactive method was used to identify mutations in the H-ras gene at codon 61 or 117 from liver neoplasms. This was based on identification of restriction fragment length polymorphism (RFLP) in the DNA containing a CAA to AAA, CTA, or CGA mutation at codon 61 of exon 2 and an AAG to AAT or AAC mutation at codon 117 of exon 3, respectively (24). The sense and antisense primers used for amplification of exon 2 were 5'-GAC ATC TTA GAC ACA GCA GTT-3' and 5'-TAG CCA TAG GTG GCT CAC CT-3'. A restriction site for MseI, XbaI, TnqI, or MfeI, HpaI enzyme (New England Biolab., Beverly, MA) is created by the presence of a C to A, A to T, A to G or G to T, or G to C mutation, respectively, at codon 61 or 117. Using this technique, we detected codon 61 AAA, CTA, CGA and codon 117 AAT, AAC mutations by MseI, XbaI, TaqI and MfeI, HpaI digestion. respectively; the normal sequence (CAA at codon 61 or AAG at codon 117) is not cut by these enzymes. The reaction was incubated at 37°C (for MseI, XbaI, MfeI, or HpaI) or 60°C (for TnqI) for 2 hr. Fifteen microliters of the mixture added with bromophenol blue dye was loaded onto the 6% polyacrylamide Tris-Borate-EDTA (TBE) gel (8 cm X 8 cm X 1 mm; 15 wells) (Novex, San Diego, CA). The gel was run at 100 V for 1 hr at room temperature (24°C) on the Novex gel elec- 
controls (Fisher's exact test).
trophoresis unit. Gels were stained with a 5 pg/ml solution of ethidium bromide for 20 min and were then destained in distilled water. Ethidium bromide-stained bands were visualized using a 3 12-nm ultraviolet viewing box and were subsequently photographed. Single-Stranded Coilformational Analysis. Singlestranded conformational analysis (SSCA) (1 8) was performed using PCR products into which [ C L -~~P I~A T P was incorporated during the inner amplification. For the first exon of K-ras, a 10% acrylamide gel containing 10% glycerol and 1 X TBE buffer was electrophoresed at room temperature with constant power at 8 W for 16 hr on a model S2 sequencing gel electrophoresis apparatus (Bethesda Research Labs, Gaithersburg, MD). For the second exon of H-ras, 12% polyacrylamide gel with 5% glycerol in 1 X TBE buffer was used at 35 W in a 4°C cold room for 5 hr.
Direct Sequericing. Direct sequencing of the amplified second exon of the K-ras gene was performed as described by Tindall and Stankowski (25) using previously described sequencing primers.
RESULTS
In order to determine if the TFE-induced neoplasms contained an H-ras mutation profile similar to that observed with spontaneously formed neoplasms, sample groups of 27 and 29 neoplasms-consisting of hepatocellular neoplasms from the 625-and 1,250-ppm exposure groups, respectively, 3 neoplasms from the 312-ppm exposure group, Bnd 17 neoplasms from the untreated control group-were evaluated by PCR amplification of H-ras exon 2 followed by RFLP and SSCA for the 3 common codon 61 mutations found in the B6C3F, mouse (Table I and Figs. 1 and 2) . For liver neoplasms from which frozen and paraffin-embedded tissues were available, both were examined to confirm the mutations. The H-ras mutations at codon 61 in both frozen and paraffinembedded liver neoplasms were detected by nonradioactive RFLP analysis (Fig. 3) .
A low frequency (9/59, 1510, p < 0.05, Fisher's exact test) of H-ras mutations at codon 61 was detected in he-1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 . 1.-Detection of mutations by SSCA in H-rus exon 2 in frozen and paraffin-embedded liver neoplasms from B6C3F, mice exposed to TFE. B6C3FI mice were exposed to 0, 312, 625, or 1.250 ppm TFE by inhalation for 6 hr/day, 5 day/wk for 2 yr. Lanes 1-3 patocellular neoplasms when compared with the high frequency (10/17, 59%) in spontaneously occurring neoplasms from the present study and from historical studies (183/333, 56%) ( Table I ). In addition, the proportion of H-ras mutations in TFE-induced hepatocellular neoplasms was 1:l:l for codon 61 AAA, CGA, and CTA mutations, respectively, compared with 3:6: 1 for controls from the present study, and 5:2:1 for spontaneously occurring hepatocellular neoplasms in historical controls (15) . There was no difference in H-rus mutation frequency and spectrum among exposure groups or between benign and malignant hepatocellular neoplasms (data not shown).
Male and female
Liver neoplasms without H-rus codon 61 mutations were also evaluated for H-rus codon 117 mutations and were found to be negative (data not shown). SSCA and direct sequencing were used as alternative methods for detection of K-ras mutations in DNA from 19 liver neoplasms after TFE exposure and from 4 controls in this study. No K-rus mutations were detected at codons 12, 13, or 61 in hepatocellular neoplasms after TFE exposure (data not shown).
DISCUSSION
The low frequency of H-rus mutations (15%) detected in hepatocellular neoplasms after TFE exposure is similar to that reported with other nongenotoxic agents such as phenobarbital (7%), chloroform (21%), and ciprofibrate (21%) when compared with the generally high frequency (56%) observed in spontaneously occurring liver neoplasms from B6C3F, mice (8, 11, 15) . Other nongenotoxic hepatocellular carcinogens associated with low frequencies of H-ms mutations include hexachlorobenzene (20), dieldrin (3), chlordane (13), methylclofenapate (23), and oxazepam (7, 16) . Nongenotoxic agents by definition are not positive in in vitro mutation assays, and therefore the parent chemical or metabolites are not believed to react with DNA directly to cause mutations. These toxicologically and pharmacologically diverse nongenotoxic hepatocarcinogens increase the incidence of liver tumors but generally are not associated with increased mutations in the H-rus gene. Instead, these agents appear to promote spontaneously initiated cells with rus mutations, or possibly tumors may be developed by pathways that do not involve a mutated H-rus (8). Our finding of a decreased frequency of H-and K-rus mutations at codons known to be frequently involved in rus activation in mouse liver neoplasms is consistent with the lack of mutagenicity in the S. typhii~ruriicin assay and the lack of detection of micronucleated erythrocytes in peripheral blood samples of mice.
The decreased frequency of H-rus mutations in TFEinduced hepatocellular neoplasms is similar to that detected in B6C3F, mice exposed for 2 yr to the structurally related chemical tetrachloroethylene (13/53, 24%) ( Table  I) (1). Unlike the lack of K-rus mutations in the TFE study, a few K-rus mutations were detected in the tetrachloroethylene study. Data from the present study further support the hypothesis that the majority of liver tumors induced by these 2 structurally related hepatocellular carcinogens may be acting via mechanisms that do not involve rus mutations. This rus-independent phenomenon has also been demonstrated with other hepatocellular carcinogens. For example, chlordane-induced hepatocarcinogenesis in B6C3FI mice was shown to be associated with a pathway where there were no rus mutations (13).
The mechanism of tumorigenesis for TFE has not been established. However, it has been proposed that the structurally related chemical tetrachloroethylene is metabolized to high levels of reactive intermediates that cause cytotoxicity, resulting in enhanced cell proliferation and carcinogenesis in the mouse liver (4, 9) . Although there was no evidence of hepatocellular cytotoxicity (e.g., necrosis, cytoplasmic change) at 16 days or 13 wk of TFE exposure, the possibility of low-level cytotoxicity and enhanced cellular proliferation, occurring after chronic exposure to TFE and thus contributing to the carcinogenesis process, could not be completely ruled out. After 2 yr of TFE exposure, there was evidence of coagulative necrosis in males, hematopoietic cell proliferation in females, and angiectasis in both males and females. Morphologically, there was no evidence that TFE may be functioning by mechanisms that have been established for other nongenotoxic chemicals such as phenobarbital or peroxisome proliferators. Additional studies at multiple time points and doses and including measurements of cellular proliferation should provide further insight into the mechanism of TFE hepatocarcinogenesis.
